Knockdown of FOXO3a resulted in salinomycin failing to reverse the EMT and overexpression of active FOXO3a caused doxorubicin to lose the capacity of inducing EMT in HCC cells. This evidence concerns the gene FOXO3 and hepatocellular carcinoma.